Arvinas, Inc.
ARVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001655759
No open-market purchases or sales by Arvinas, Inc. insiders were filed in the last 90 days; 201 institutions reported holding it in 13F filings for Q2 2026, worth $468.7M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Arvinas, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 199
- −5 vs. Q3 2024
- Shares held
- 76.6M
- +4.33M (+6.0%) vs. Q3 2024
- Total value
- $1.47B
- −$309.0M (−17.4%) vs. Q3 2024
- New holders
- 30
- 79 more added
- Sold out
- 35
- 53 more reduced
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 201 | $468.7M |
| Q1 2026 | 207 | $572.6M |
| Q4 2025 | 206 | $662.9M |
| Q3 2025 | 211 | $570.7M |
| Q2 2025 | 215 | $513.8M |
| Q1 2025 | 216 | $456.7M |
| Q4 2024 | 199 | $1.47B |
| Q3 2024 | 206 | $1.78B |
| Q2 2024 | 207 | $1.89B |
| Q1 2024 | 223 | $2.84B |
| Q4 2023 | 213 | $2.67B |
| Q3 2023 | 155 | $959.0M |
| Q2 2023 | 156 | $1.16B |
| Q1 2023 | 171 | $1.34B |
| Q4 2022 | 162 | $1.71B |
| Q3 2022 | 174 | $2.22B |
| Q2 2022 | 172 | $2.08B |
| Q1 2022 | 179 | $3.16B |
| Q4 2021 | 199 | $3.69B |
| Q3 2021 | 205 | $3.64B |
| Q2 2021 | 181 | $3.52B |
| Q1 2021 | 181 | $2.88B |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Arvinas, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Voya Investment Management LLC | 39,678 | $760.6K | 0.00% | −19,312−32.7% | Reduced |
| Wells Fargo & Company | 41,610 | $797.7K | 0.00% | −18,789−31.1% | Reduced |
| BNP Paribas Arbitrage, SA | 44,592 | $854.8K | 0.00% | +7,243+19.4% | Added |
| Victory Capital Management Inc | 45,450 | $871.3K | 0.00% | −1,070−2.3% | Reduced |
| California State Teachers Retirement System | 46,111 | $883.9K | 0.00% | −405−0.9% | Reduced |
| Yelin Lapidot Holdings Management Ltd. | 46,873 | $898.6K | 0.16% | −2,630−5.3% | Reduced |
| Simplex Trading, LLC | 46,907 | $899.0K | 0.03% | +38,923+487.5% | Added |
| Federated Hermes, Inc. | 47,491 | $910.4K | 0.00% | −86,719−64.6% | Reduced |
| State of Wisconsin Investment Board | 49,749 | $953.7K | 0.00% | +4,707+10.5% | Added |
| Sit Investment Associates Inc | 51,594 | $989.0K | 0.02% | +16,693+47.8% | Added |
| Legal & General Group Plc | 53,610 | $1.03M | 0.00% | −3,989−6.9% | Reduced |
| Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group | 57,500 | $1.10M | 0.64% | 00.0% | Unchanged |
| Schroder Investment Management Group | 58,052 | $1.10M | 0.00% | +34,283+144.2% | Added |
| HighVista Strategies LLC | 58,001 | $1.11M | 0.41% | 00.0% | Unchanged |
| Verition Fund Management LLC | 60,529 | $1.16M | 0.01% | +21,898+56.7% | Added |
| Hennion & Walsh Asset Management, Inc. | 63,477 | $1.22M | 0.06% | −648−1.0% | Reduced |
| Citigroup Inc | 64,526 | $1.24M | 0.00% | +6,262+10.7% | Added |
| Susquehanna International Group, LLP | 65,209 | $1.25M | 0.00% | +65,209 | New |
| Prelude Capital Management, LLC | 65,400 | $1.25M | 0.11% | +65,400 | New |
| Renaissance Technologies LLC | 68,900 | $1.32M | 0.00% | −75,500−52.3% | Reduced |
| Alliancebernstein L.P. | 73,720 | $1.41M | 0.00% | 00.0% | Unchanged |
| Engineers Gate Manager LP | 74,651 | $1.43M | 0.02% | +44,919+151.1% | Added |
| Qube Research & Technologies Ltd | 76,198 | $1.46M | 0.00% | −133,711−63.7% | Reduced |
| Standard Life Aberdeen plc | 78,585 | $1.51M | 0.00% | 00.0% | Unchanged |
| Edmond de Rothschild Holding S.A. | 80,000 | $1.53M | 0.03% | +80,000 | New |
| DekaBank Deutsche Girozentrale | 42,000 | $1.65M | 0.00% | 00.0% | Unchanged |
| Zacks Investment Management | 86,448 | $1.66M | 0.02% | −3,379−3.8% | Reduced |
| Patient Square Capital LP | 86,627 | $1.66M | 0.62% | +86,627 | New |
| Rhumbline Advisers | 87,877 | $1.68M | 0.00% | +754+0.9% | Added |
| Graham Capital Management, L.P. | 87,879 | $1.68M | 0.05% | +24,303+38.2% | Added |
| Manufacturers Life Insurance Company, The | 89,540 | $1.72M | 0.00% | −866−1.0% | Reduced |
| Nomura Asset Management Co Ltd | 90,870 | $1.74M | 0.01% | 00.0% | Unchanged |
| Swiss National Bank | 94,000 | $1.80M | 0.00% | 00.0% | Unchanged |
| Parkman Healthcare Partners LLC | 106,871 | $2.05M | 0.27% | +10,688+11.1% | Added |
| Banque Pictet & Cie SA | 110,619 | $2.12M | 0.02% | −10,205−8.4% | Reduced |
| Jane Street Group, LLC | 110,722 | $2.12M | 0.00% | −26,573−19.4% | Reduced |
| Ameriprise Financial Inc | 116,513 | $2.23M | 0.00% | +19,505+20.1% | Added |
| TD Asset Management Inc | 122,348 | $2.35M | 0.00% | +48,800+66.4% | Added |
| Bank of America Corp | 128,755 | $2.47M | 0.00% | −315,298−71.0% | Reduced |
| Assenagon Asset Management S.A. | 140,518 | $2.69M | 0.00% | +777+0.6% | Added |
| Rhenman & Partners Asset Management AB | 155,500 | $2.98M | 0.31% | +25,000+19.2% | Added |
| Twinbeech Capital LP | 164,112 | $3.15M | 0.05% | +164,112 | New |
| Neuberger Berman Group LLC | 164,392 | $3.15M | 0.00% | +5,762+3.6% | Added |
| Barclays PLC | 175,019 | $3.36M | 0.00% | +53,320+43.8% | Added |
| Bank of New York Mellon Corp | 175,913 | $3.37M | 0.00% | −13,891−7.3% | Reduced |
| Gilder Gagnon Howe & Co LLC | 186,594 | $3.58M | 0.04% | −7,749−4.0% | Reduced |
| Algert Global LLC | 205,988 | $3.95M | 0.09% | +37,927+22.6% | Added |
| Caption Management, LLC | 206,915 | $3.97M | 0.16% | +206,915 | New |
| Kennedy Capital Management, Inc. | 208,992 | $4.01M | 0.09% | +61,802+42.0% | Added |
| Deutsche Bank AG | 217,220 | $4.16M | 0.00% | −13,166−5.7% | Reduced |
| Exome Asset Management LLC | 218,700 | $4.19M | 3.15% | +218,700 | New |
| Nuveen Asset Management, LLC | 224,273 | $4.30M | 0.00% | −1,725−0.8% | Reduced |
| Nordea Investment Management AB | 232,886 | $4.40M | 0.00% | +9,196+4.1% | Added |
| American Century Companies Inc | 252,685 | $4.84M | 0.00% | −58,788−18.9% | Reduced |
| BIT Capital GmbH | 263,527 | $5.05M | 0.44% | +196,246+291.7% | Added |
| Marshall Wace, LLP | 268,026 | $5.14M | 0.01% | +97,676+57.3% | Added |
| Two Sigma Advisers, LP | 282,600 | $5.42M | 0.01% | +55,000+24.2% | Added |
| Frazier Life Sciences Management, L.P. | 285,331 | $5.47M | 0.23% | 00.0% | Unchanged |
| Panagora Asset Management Inc | 297,186 | $5.70M | 0.03% | +35,475+13.6% | Added |
| Millennium Management LLC | 314,843 | $6.04M | 0.01% | +106,218+50.9% | Added |
| Aquilo Capital Management, LLC | 328,766 | $6.30M | 10.79% | −60,000−15.4% | Reduced |
| Two Sigma Investments, LP | 397,502 | $7.62M | 0.02% | +11,233+2.9% | Added |
| Baker Bros. Advisors LP | 405,576 | $7.77M | 0.08% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 421,348 | $8.08M | 0.11% | 00.0% | Unchanged |
| UBS Asset Management Americas Inc | 433,531 | $8.31M | 0.00% | +3,047+0.7% | Added |
| Wasatch Advisors Inc | 436,241 | $8.36M | 0.04% | +298+0.1% | Added |
| Goldman Sachs Group Inc | 492,838 | $9.45M | 0.00% | −261,288−34.6% | Reduced |
| Candriam Luxembourg S.C.A. | 503,936 | $9.66M | 0.06% | −20,845−4.0% | Reduced |
| Charles Schwab Investment Management Inc | 536,112 | $10.3M | 0.00% | +5,443+1.0% | Added |
| Affinity Asset Advisors, LLC | 630,000 | $12.1M | 1.89% | +405,000+180.0% | Added |
| Northern Trust Corp | 631,131 | $12.1M | 0.00% | +42,638+7.2% | Added |
| Schonfeld Strategic Advisors LLC | 656,100 | $12.6M | 0.08% | +300,295+84.4% | Added |
| Woodline Partners LP | 692,733 | $13.3M | 0.09% | +194,996+39.2% | Added |
| Logos Global Management LP | 700,000 | $13.4M | 1.57% | +300,000+75.0% | Added |
| Finepoint Capital LP | 713,778 | $13.7M | 1.58% | +139,400+24.3% | Added |
| Perceptive Advisors LLC | 740,749 | $14.2M | 0.40% | −287,000−27.9% | Reduced |
| Dimensional Fund Advisors LP | 843,430 | $16.2M | 0.00% | +186,254+28.3% | Added |
| Morgan Stanley | 1,000,181 | $19.2M | 0.00% | +477,588+91.4% | Added |
| Boxer Capital Management, LLC | 1,058,614 | $20.3M | 1.73% | +1,058,614 | New |
| Norges Bank | 1,243,868 | $23.8M | 0.00% | −79,565−6.0% | Reduced |
| Avidity Partners Management LP | 1,358,000 | $26.0M | 2.60% | −139,000−9.3% | Reduced |
| Nextech Invest AG | 1,408,394 | $27.0M | 4.38% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 1,511,014 | $29.0M | 0.00% | −8,320−0.5% | Reduced |
| FMR LLC | 1,558,827 | $29.9M | 0.00% | −1,324,777−45.9% | Reduced |
| New Leaf Venture Partners, L.L.C. | 1,585,721 | $30.4M | 40.64% | +151,000+10.5% | Added |
| State Street Corp | 1,637,050 | $31.4M | 0.00% | −6,677−0.4% | Reduced |
| Opaleye Management Inc. | 1,625,000 | $33.6M | 5.89% | +370,000+29.5% | Added |
| ArrowMark Colorado Holdings LLC | 1,776,555 | $34.1M | 0.46% | +532,105+42.8% | Added |
| JPMorgan Chase & Co | 1,857,078 | $35.6M | 0.00% | −472,225−20.3% | Reduced |
| UBS Group AG | 2,038,459 | $39.1M | 0.01% | +1,566,881+332.3% | Added |
| T. Rowe Price Investment Management, Inc. | 2,208,234 | $42.3M | 0.03% | +2,208,234 | New |
| Bellevue Group AG | 2,389,600 | $45.8M | 0.88% | +3,000+0.1% | Added |
| Citadel Advisors LLC | 3,072,668 | $58.9M | 0.05% | +365,117+13.5% | Added |
| RTW Investments, LP | 3,334,308 | $63.9M | 0.97% | +551,979+19.8% | Added |
| Pfizer Inc | 3,457,815 | $66.3M | 2.56% | +3,457,815 | New |
| Price T Rowe Associates Inc | 4,103,011 | $78.7M | 0.01% | +249,295+6.5% | Added |
| BlackRock, Inc. | 6,566,145 | $125.9M | 0.00% | +70,059+1.1% | Added |
| EcoR1 Capital, LLC | 6,726,491 | $128.9M | 5.17% | 00.0% | Unchanged |
| Vanguard Group Inc | 7,062,561 | $135.4M | 0.00% | +56,561+0.8% | Added |
| Paradigm Biocapital Advisors LP | 0 | $0 | 0.00% | −2,339,961−100.0% | Sold out |